edgepedia

All articles A–Z

519,064 articles

Ptolemy III Euergetes

Ptolemy III Euergetes, meaning "the Benefactor", was a Greek king of the Ptolemaic dynasty who ruled Egypt from 246 to 222 BC, son of Ptolemy II.

Ptolemy IV Philopator

Ptolemy IV Philopator (Ptolemaios Philopator) was a Ptolemaic king of Egypt, reigning from 222 to 204 BC and defeating Antiochus III at Raphia in 217 BC.

Ptolemy IX Soter

Ptolemy IX Soter, also called Ptolemy Lathyrus, was a Macedonian king of Egypt of the Ptolemaic dynasty, ruling 116–107 BC and again 88–81/80 BC after exile in Cyprus.

Ptolemy Macron

Ptolemy Macron was a Ptolemaic official who governed Cyprus under Ptolemy VI Philometor, deserted to Antiochus IV Epiphanes, was rewarded with Coele-Syria and Phoenicia, and died by poison.

Ptolemy of Cyprus

Ptolemy of Cyprus, also called Ptolemy, king of Cyprus, was the last Ptolemaic king of Cyprus, ruling from 80 BC until Roman annexation in 58 BC.

Ptolemy Philadelphus (Πτολεμαῖος Φιλάδελφος) (son of Cleopatra)

Ptolemy Philadelphus (Πτολεμαῖος Φιλάδελφος), youngest son of Cleopatra VII and Mark Antony, born c. 36 BC; named king of Phoenicia, Syria, and Cilicia at the Donations of Alexandria, later under Octavia's guardianship, fate unknown.

Ptolemy V Epiphanes

Ptolemy V Epiphanes, also known as Ptolemy Epiphanes, was a king of Ptolemaic Egypt who reigned from 204 to 180 BC and is best known from the Rosetta Stone decree of 196 BC.

Ptolemy VI Philometor

Ptolemy VI Philometor, also known as Ptolemy Philometor, was a Greek Macedonian king of Ptolemaic Egypt who reigned 180–164 and 163–145 BCE, dying in Syria in 145.

Ptolemy VII Neos Philopator

Ptolemy VII Neos Philopator is the conventional name for a shadowy Ptolemaic prince of second-century BC Egypt, probably Ptolemy Memphites, murdered by his father around 130 BC.

Ptolemy VIII Physcon

Ptolemy VIII Physcon, also known as Ptolemy VIII Euergetes II, was a king of Ptolemaic Egypt who reigned, with interruptions, from 170 BC until his death in 116 BC.

Ptolemy X Alexander I

Ptolemy X Alexander I (Ptolemy Alexander) was a king of Ptolemaic Egypt who ruled from 107 to 88 BC, displacing his brother Ptolemy IX, and died trying to retake the kingdom.

Ptolemy XI Alexander II

Ptolemy XI Alexander II, also known as Ptolemy Alexander II, was a king of Ptolemaic Egypt whose reign of about 18 days in 80 BC ended in lynching.

Ptolemy XII Auletes

Ptolemy XII Auletes (Neos Dionysos), Ptolemaic king of Egypt 80-58 and 55-51 BCE and father of Cleopatra VII; known for his flute-playing nickname, 6,000-talent alliance with Rome in 59 BCE, 58 BCE exile under Berenice IV, and restoration by Gabinius in 55 BCE.

Ptolemy XIII Theos Philopator

Ptolemy XIII Theos Philopator (62/61–47 BCE), Ptolemaic pharaoh of Egypt from 51 BCE, brother-husband and rival of Cleopatra VII; ordered Pompey's murder, fought Caesar in the Alexandrian War, and drowned in the Nile after the Battle of the Nile, aged about 15.

Ptolemy XIV

Ptolemy XIV Philopator was a king of Ptolemaic Egypt, younger brother of Cleopatra VII, her nominal co-ruler from 47 BC until his death in 44 BC.

Ptolemy, son of Agesarchos

Ptolemy, son of Agesarchos (Greek: Πτολεμαῖος ὁ Ἀγησάρχου) was a Ptolemaic official of Arcadian origin who served as strategos, or governor, of Cyprus in the 2nd century BC.

Ptosis (breasts)

Breast ptosis (breast sagging): descent of breast tissue and nipple-areola complex below the inframammary fold, graded I-III plus pseudoptosis by Regnault's 1976 classification; treated by mastopexy, with recurrence the main long-term issue.

Ptosis (eyelid)

Ptosis (blepharoptosis) is drooping of the upper eyelid margin, classified as aponeurotic, myogenic, neurogenic, or mechanical. Treated mainly by surgery; oxymetazoline 0.1% is the only FDA-approved drug for adults.

PTPN1

PTPN1, also called PTP1B (protein tyrosine phosphatase 1B), is a human gene and founding PTP-family enzyme that negatively regulates insulin and leptin signaling; a validated diabetes and obesity drug target hindered by TCPTP selectivity and bioavailability problems.

PTPN11

PTPN11, also called SHP2, is a human gene encoding a non-receptor protein tyrosine phosphatase. Germline mutations cause Noonan and LEOPARD syndromes; somatic mutations drive childhood leukemia.

PTPN12

PTPN12 (PTP-PEST, PTPG1), Gene ID 5782, is a ubiquitously expressed human non-receptor protein tyrosine phosphatase with a C-terminal PEST motif that regulates FAK, HER2/EGFR, and adhesion signaling; its expression is a context-dependent cancer biomarker.

PTPN2

PTPN2, also called TCPTP or TC-PTP, encodes a ubiquitous non-receptor protein tyrosine phosphatase on chromosome 18p11 with nuclear (TC45) and ER (TC48) isoforms, regulating insulin, JAK/STAT, and TCR signaling, autoimmune risk, and cancer immunotherapy.

PTPN22

PTPN22 is a human gene on chromosome 1 that encodes lymphoid tyrosine phosphatase, which dampens T cell receptor signaling; its C1858T variant is among the strongest genetic risk factors for autoimmunity.

PTPN6

PTPN6 (SHP-1, HCP, PTP-1C) is a human gene at 12p13.31 encoding a SH2-domain-containing tyrosine phosphatase, a negative immune regulator; biallelic loss-of-function causes infant anemia and inflammatory lung disease.

PTPRC

PTPRC (CD45, leukocyte common antigen) encodes a transmembrane receptor protein tyrosine phosphatase on nearly all nucleated hematopoietic cells; alternatively spliced exons 4-6 yield CD45RA/RB/RO isoforms that mark naive versus memory lymphocytes and regulate antigen receptor signaling.

PTPRZ1

PTPRZ1 (RPTPζ, phosphacan) is a human chromosome 7 gene encoding a CNS-restricted receptor-type tyrosine phosphatase; pleiotrophin inhibits it via dimerization, and it is implicated in glioma, remyelination, and schizophrenia.

PTRG study

PTRG-DES consortium (PTRG study), a South Korean multicenter registry of 13,160 drug-eluting stent patients (2003-2018) linking platelet function tests and CYP2C19 genotype to long-term outcomes on clopidogrel.

PTRS-41

The PTRS-41 is a Soviet gas-operated, semi-automatic anti-tank rifle designed by Sergei Simonov and adopted in 1941, firing the 14.5×114 mm cartridge alongside the bolt-action PTRD-41.

PTSD Symptom Scale

The PTSD Symptom Scale (PSS) is a brief trauma measure, in interview and self-report versions, that yields a PTSD diagnosis and a severity score; Foa and colleagues published it in 1993.

PTSD-REA trial

PTSD-REA (NCT03991611) is a French stepped wedge cluster randomized trial led by Pierre Kalfon, Centre Hospitalier of Chartres, testing whether the IPREA3 discomfort-reduction program lowers PTSD symptoms (PCL-5) in ICU survivors at 1 year; 3,312 participants, 33 sites, including a COVID cohort.